SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 14th, 2022 • Aveo Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 14th, 2022 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this 10th day of March 2021 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 30 Winter Street Boston, MA 02108 (the “Company”), and Michael Ferraresso (the “Employee”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 16th, 2020 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 16th, 2020 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this 6th day of January 2020 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 1 Broadway 14th Floor, Cambridge, MA 02142 (the “Company”), and Erick Lucera (the “Employee”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 14th, 2019 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 14th, 2019 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this 13th day of March 2019 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 1 Broadway 14th Floor, Cambridge, MA 02142 (the “Company”), and Karuna Rubin (the “Employee”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 13th, 2018 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 13th, 2018 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this ____day of November 2017 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 1 Broadway 14th Floor, Cambridge, MA 02142 (the “Company”), and Nikhil Mehta (the “Employee”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • November 20th, 2017 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 20th, 2017 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”), made this 20th day of November 2017 (the “Effective Date”), is entered into by AVEO Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 1 Broadway 14th Floor, Cambridge, MA 02142 (the “Company”), and Matthew Dallas (the “Employee”).